Skip to content

PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | The NEW ENGLAND JOURNAL Of MEDICINE

Authors: Andrea Cercek, M.D., Melissa Lumish, M.D. https://orcid.org/0000-0003-4173-5567, Jenna Sinopoli, N.P., Jill Weiss, B.A., Jinru Shia, M.D., MichelleLamendola-Essel, D.H.Sc., Imane H. El Dika, M.D., and Luis A. Diaz, Jr., M.D.

BACKGROUND

Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair. Because mismatch repair–deficient colorectal cancer is responsive to programmed death 1 (PD-1) blockade in the context of metastatic disease, it was hypothesized that checkpoint blockade could be effective in patients with mismatch repair–deficient, locally advanced rectal cancer.

METHODS

We initiated a prospective phase 2 study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery. Patients who had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery. The primary end points are sustained clinical complete response 12 months after completion of dostarlimab therapy or pathological complete response after completion of dostarlimab therapy with or without chemoradiotherapy and overall response to neoadjuvant dostarlimab therapy with or without chemoradiotherapy.
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

RESULTS

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months). No adverse events of grade 3 or higher have been reported.

CONCLUSIONS

Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.)
Locally advanced rectal cancer is typically managed with multimodal therapy, including chemotherapy, radiation, and surgery. Current evidence supports a strategy involving the use of neoadjuvant therapy, in which induction chemotherapy with a fluoropyrimidine in combination with oxaliplatin is followed by chemoradiotherapy and then surgery.1-3 This approach results in a pathological complete response in up to a quarter of patients, but it is associated with marked complications and toxic effects — including bowel, urinary, and sexual dysfunction; infertility; and altered quality of life — in a substantial proportion of patients.4-6 In patients undergoing surgery, resection of the rectum is life-altering and often warrants a permanent diverting colostomy.6,7 Owing to the complications of surgery and the high frequency of pathological complete response, interest in organ-sparing nonoperative management is increasing. The use of clinical complete response that is achieved with neoadjuvant treatment as a surrogate for pathological complete response provides patients with a nonoperative option that results in a survival benefit that is similar to that in patients undergoing surgical resection.8-11
Approximately 5 to 10% of rectal adenocarcinomas are mismatch-repair deficient, and these tumors have been shown to respond poorly to standard chemotherapy regimens, including neoadjuvant chemotherapy in locally advanced rectal cancer.12-14 Immune checkpoint blockade alone has been shown to be highly effective as first-line treatment for patients with mismatch repair–deficient metastatic colorectal cancer, as well as for patients with treatment-refractory disease, with objective response rates of 33 to 55%, clinically significant durability of response, and prolonged overall survival.15-17
On the basis of the benefits seen in the context of metastatic disease, we hypothesized that single-agent programmed death 1 (PD-1) blockade alone might be beneficial in mismatch repair–deficient, locally advanced rectal cancer. To test this hypothesis, we initiated a phase 2 study to investigate the overall response and frequency of sustained clinical complete response to neoadjuvant treatment with dostarlimab, a PD-1 inhibitor, in this patient population.

Skip The Scoop | Seek Understanding

Facebook oversight board member rips social media giant as ‘inconsistent’ after Trump ban

Show Me

Utah County Censures Mitt Romney for Trump Impeachment Vote

Show Me

A Majority of Americans Support ‘Vaccine Passports’ for Some Activities, Poll Finds

Show Me

There Are Simple Reasons Liz Cheney Has To Go

Show Me

Scarlett Johansson urges boycott of ‘sexist’ Golden Globes unless organizers implement major reforms

Show Me

Biden’s new left of racial radicals: Goodwin

Show Me

Establishment Media Still Fixated on Donald Trump Four Months After Office

Show Me

Asian Parents Rally Against NYC Schools Chancellor

Show Me

Gordon Chang: Communist China Has Committed ‘Mass Murder’ of Americans

Show Me

Success Academy requiring all employees get vaccinated for COVID-19

Show Me

Lockdown ‘has helped to rot kids’ teeth’: Number of children with dental decay is set to soar

Show Me

As A Mother Grows

Show Me

Here’s How You Know Democrats Rigged and Stole the 2020 Election

Show Me

Nearly 9 out of 10 young adults want a Covid inoculation, survey finds 

Show Me

Minnesota gets creative in COVID-19 vaccine outreach

Show Me

Apparently, We See Once Again Everyone Is Vulnerable Except Dominion Voting Systems | “Ransomware Attackers Up Ante as White House Vows Crack Down”

Show Me

With Trump On The Sidelines & Biden In | “Jerusalem sees second night of clashes as Israeli security forces block Muslim pilgrims at mosque”

Show Me

Astronomers observe black hole ‘spaghettification’ of a star for the first time

Show Me

Arizona Formally Bans Post-Election Signature Fix for Unsigned Mail-In Ballots

Show Me

Trump planned Qassem Soleimani’s assassination from 2017 and wanted to wipe out a ‘list of folks’

Show Me

Feminist Author Naomi Wolf: Democrats Are ‘In An Embrace With Big Tech’ To ‘Consolidate Power’ | Video: 5 Minutes 1 Second

Show Me

POLICE STATE: Watch the moment a SWAT team arrests a Canadian pastor | Video: 2 Minutes 58 Seconds

Show Me

UMass Amherst students suspended for partying outside without masks

Show Me

From Peaceniks of 1960s to the Social Justice Warriors of 2020s: Some Cultural and Spiritual Insights

Show Me

Pope Francis Calls for ‘Temporary Suspension’ of Property Rights to Vaccines During ‘Vax Live’ Concert

Show Me

Violent Crime Surged in These Cities After Mass Black Lives Matter, Anti-Police Protests

Show Me

Gwyneth Paltrow drank whiskey ‘every night’ during COVID-19 lockdown

Show Me

The Civics Secures Democracy Act Is a Neo-Marxist Trojan Horse

Show Me

Bannon’s War Room | Saturday Edition Hour 1 | Recorded May 8, 2021 | Video: 48 Minutes 23 Seconds

Show Me

Bannon’s War Room | Saturday Edition Hour 2 | Recorded May 8, 2021 | Video: 48 Minutes 18 Seconds

Show Me

CDC Changes Rules for Counting Breakthrough Cases, as More Fully Vaccinated People Test Positive

Show Me

Woman In Mali Expecting Seven Babies Gives Birth To Nine

Show Me

Hundreds Of Children Were Shot In 2020 and Into 2021. Many Of Their Assailants Have Not Been Caught

Show Me

Exclusive—Josh Hawley Keeps His Children off Social Media: ‘Their Business Model Is Addiction’

Show Me

Rutgers to enroll 200 kids to take part in Pfizer COVID vaccine trial

Show Me

Apparently, Only Americans Are To Be Stalked By U.S. Government ‘Leaders’ | “Biden Order Rescinds Trump Plan to Collect Facial Scans, DNA From Immigrants”

Show Me

Krista Kafer: Will vaccine requirements set precedent we will regret?

Show Me

In-person school should be ‘mandatory’ for CPS students in the fall, CPS CEO says (Chicago)

Show Me

WATCH: Michelle Obama Claims That Black Lives Matter is ‘Taking to the Streets Because They Have To’

Show Me

More than 2,100 migrant children abandoned relatives to cross border alone after Biden took office

Show Me